SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-103463
Filing Date
2020-09-09
Accepted
2020-09-09 16:22:39
Documents
12
Period of Report
2020-09-09
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030337-5_8k.htm   iXBRL 8-K 23222
  Complete submission text file 0001104659-20-103463.txt   196317

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA albo-20200909.xsd EX-101.SCH 3201
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20200909_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20200909_pre.xml EX-101.PRE 22720
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2030337-5_8k_htm.xml XML 3585
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 201166756
SIC: 2834 Pharmaceutical Preparations